Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection.
Mycobacterium tuberculosis infection induces complex CD4 T cell responses that include T helper type 1 (Th1) cells and regulatory T cells. Although Th1 cells control infection, they are unable to fully eliminate M. tuberculosis, suggesting that Th1-mediated immunity is restrained from its full sterilizing potential. Investigation into T cell-mediated defense is hindered by difficulties in expanding M. tuberculosis-specific T cells. To circumvent this problem, we cloned CD4(+) T cells from M. tuberculosis-infected B6 mice and generated transgenic mice expressing a T cell receptor specific for the immunodominant antigen early secreted antigenic target 6 (ESAT-6). Adoptively transferred naive ESAT-6-specific CD4(+) T cells are activated in pulmonary lymph nodes between 7 and 10 d after aerosol infection and undergo robust expansion before trafficking to the lung. Adoptive transfer of activated ESAT-6-specific Th1 cells into naive recipients before aerosol M. tuberculosis infection dramatically enhances resistance, resulting in 100-fold fewer bacteria in infected lungs. However, despite large numbers of Th1 cells in the lungs of mice at the time of M. tuberculosis challenge, protection was not manifested until after 7 d following infection. Our results demonstrate that pathogen-specific Th1 cells can provide protection against inhaled M. tuberculosis, but only after the first week of infection.
Gallegos
Alena M
AM
Infectious Diseases Service, Immunology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10032, USA.
Pamer
Eric G
EG
Glickman
Michael S
MS
D019264:Adoptive Transfer; D000818:Animals; D000942:Antigens, Bacterial / Q000276:immunology*; D001426:Bacterial Proteins / Q000276:immunology*; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology*; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D009169:Mycobacterium tuberculosis / Q000276:immunology* / Q000502:physiology; D011948:Receptors, Antigen, T-Cell / Q000235:genetics / Q000378:metabolism; D018417:Th1 Cells / Q000276:immunology; D013997:Time Factors; D014376:Tuberculosis / Q000276:immunology* / Q000517:prevention & control
D000942:Antigens, Bacterial; D001426:Bacterial Proteins; C093276:ESAT-6 protein, Mycobacterium tuberculosis; D011948:Receptors, Antigen, T-Cell
J Immunol. 1999 May 1;162(9):5407-16
10228018
Immunity. 1995 Jun;2(6):561-72
7540941
Immunology. 2006 Jun;118(2):195-201
16771854
Infect Immun. 1995 May;63(5):1710-7
7729876
J Immunol. 2007 Mar 1;178(5):2661-5
17312107
Infect Immun. 1998 Feb;66(2):830-4
9453650
J Immunol. 1998 Nov 1;161(9):4882-93
9794422
Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 1):717-20
11254530
Annu Rev Immunol. 2004;22:599-623
15032590
J Clin Invest. 2005 Sep;115(9):2472-9
16110326
J Exp Med. 2007 Sep 3;204(9):2159-69
17709423
Ann Intern Med. 1997 Jan 15;126(2):123-32
9005746
J Immunol. 1996 Oct 15;157(8):3527-33
8871652
Eur J Immunol. 1998 Dec;28(12):3949-58
9862331
J Immunol. 2001 Mar 1;166(5):3432-9
11207301
J Exp Med. 2001 Feb 5;193(3):271-80
11157048
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):13001-6
14557536
Cell Immunol. 2000 Apr 10;201(1):63-74
10805975
J Immunol. 2003 Aug 1;171(3):1602-9
12874255
J Exp Med. 2002 Oct 7;196(7):957-68
12370257
Infect Immun. 2001 May;69(5):2773-8
11292688
J Exp Med. 1993 Dec 1;178(6):2249-54
7504064
J Immunol. 1999 Oct 1;163(7):3898-906
10490990
J Immunol. 2007 Apr 15;178(8):4721-5
17404250
J Exp Med. 1993 Dec 1;178(6):2243-7
8245795
J Immunol. 2003 Feb 15;170(4):2046-52
12574375
J Immunol Methods. 1995 Sep 11;185(1):133-40
7665895
N Engl J Med. 2001 Oct 11;345(15):1098-104
11596589
Trends Microbiol. 2004 Nov;12(11):500-8
15488391
Infect Immun. 2001 Feb;69(2):800-9
11159971
Infect Immun. 2002 Aug;70(8):4501-9
12117962
Immunity. 2006 Oct;25(4):665-75
17027299
J Exp Med. 2001 Nov 19;194(10):1421-32
11714749
J Exp Med. 2005 Jun 20;201(12):1915-24
15955839
J Immunol. 2007 Aug 15;179(4):2509-19
17675513
Nat Rev Microbiol. 2005 Aug;3(8):656-62
16012514
Immunity. 2008 Feb;28(2):271-84
18261937
N Engl J Med. 1999 Oct 14;341(16):1174-9
10519895
Mol Microbiol. 2002 Nov;46(3):709-17
12410828
Science. 1993 May 14;260(5110):984-6
8098550
Infect Immun. 2006 Jul;74(7):3790-803
16790751
Nat Immunol. 2007 Apr;8(4):369-77
17351619
J Exp Med. 2008 Jan 21;205(1):105-15
18158321
Lancet Infect Dis. 2004 Dec;4(12):739-49
15567123
J Immunol. 2005 Jul 15;175(2):1107-17
16002712